首页> 美国卫生研究院文献>Marine Drugs >A Structure- and Ligand-Based Virtual Screening of a Database of Small Marine Natural Products for the Identification of Blue Sigma-2 Receptor Ligands
【2h】

A Structure- and Ligand-Based Virtual Screening of a Database of Small Marine Natural Products for the Identification of Blue Sigma-2 Receptor Ligands

机译:基于结构和配体的小海洋天然产物数据库的虚拟筛选用于鉴定蓝色 Sigma-2受体配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sigma receptors are a fascinating receptor protein class whose ligands are actually under clinical evaluation for the modulation of opioid analgesia and their use as positron emission tomography radiotracers. In particular, peculiar biological and therapeutic functions are associated with the sigma-2 (σ2) receptor. The σ2 receptor ligands determine tumor cell death through apoptotic and non-apoptotic pathways, and the overexpression of σ2 receptors in several tumor cell lines has been well documented, with significantly higher levels in proliferating tumor cells compared to quiescent ones. This acknowledged feature has found practical application in the development of cancer cell tracers and for ligand-targeting therapy. In this context, the development of new ligands that target the σ2 receptors is beneficial for those diseases in which this protein is involved. In this paper, we conducted a search of new potential σ2 receptor ligands among a database of 1517 “small” marine natural products constructed by the union of the Seaweed Metabolite and the Chemical Entities of Biological Interest (ChEBI) Databases. The structures were passed through two filters that were constituted by our developed two-dimensional (2D) and three-dimensional Quantitative Structure-Activity Relationship (3D-QSAR) statistical models, and successively docked upon a σ2 receptor homology model that we built according to the FASTA sequence of the σ2/TMEM97 (SGMR2_HUMAN) receptor.
机译:Sigma受体是一种引人入胜的受体蛋白,其配体实际上正在接受临床评估,以调节阿片类药物的镇痛作用,并将其用作正电子发射断层扫描放射示踪剂。特别是,特殊的生物学和治疗功能与sigma-2(σ2)受体有关。 σ2受体配体通过凋亡和非凋亡途径决定肿瘤细胞的死亡,并且已经充分证明了σ2受体在几种肿瘤细胞系中的过度表达,与静止状态相比,增殖中的肿瘤细胞水平明显更高。该公认的特征已在癌细胞示踪剂的开发和配体靶向疗法中得到实际应用。在这种情况下,针对σ2受体的新配体的开发对于涉及该蛋白的那些疾病是有益的。在本文中,我们在1517个“小”海洋天然产物数据库中进行了新的潜在σ2受体配体的搜索,这些数据库是由海藻代谢产物和生物兴趣化学实体(ChEBI)数据库的联合建立的。结构通过两个由我们开发的二维(2D)和三维定量结构-活动关系(3D-QSAR)统计模型构成的过滤器,并依次停靠在我们根据建立的σ2受体同源性模型上σ2/ TMEM97(SGMR2_HUMAN)受体的FASTA序列。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号